Institutional investors purchased a net $577.4 thousand shares of TROV during the quarter ended March 2016, and now own 34.36% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FSC SECURITIES CORP. Bought 87.0 Thousand shares of Trovagene Inc
SSGA FUNDS MANAGEMENT, INC. Bought 68.6 Thousand shares of Trovagene Inc